The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding
Extracorporeal membrane oxygenation (ECMO) is increasingly used in carefully selected patients with cardiac or respiratory failure. However, complications are common and can be associated with worse outcomes, while data on risk factors and outcomes are inconsistent and sparse. Therefore, we sought t...
Main Authors: | Sasa Rajsic, Robert Breitkopf, Ulvi Cenk Oezpeker, Zoran Bukumirić, Moritz Dobesberger, Benedikt Treml |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/9/2314 |
Similar Items
-
Association of aPTT-Guided Anticoagulation Monitoring with Thromboembolic Events in Patients Receiving V-A ECMO Support: A Systematic Review and Meta-Analysis
by: Sasa Rajsic, et al.
Published: (2023-04-01) -
ECMO in Cardiogenic Shock: Time Course of Blood Biomarkers and Associated Mortality
by: Sasa Rajsic, et al.
Published: (2022-11-01) -
ECMO in Myocardial Infarction-Associated Cardiogenic Shock: Blood Biomarkers as Predictors of Mortality
by: Thomas Senoner, et al.
Published: (2023-12-01) -
ECMO Support in Refractory Cardiogenic Shock: Risk Factors for Mortality
by: Sasa Rajsic, et al.
Published: (2022-11-01) -
ECMO Predictors of Mortality: A 10-Year Referral Centre Experience
by: Benedikt Treml, et al.
Published: (2022-02-01)